Back to Browse Journals » Eye and Brain » Volume 2

Scanning training in neurological vision loss: case studies

Authors Paul Koons, Scott Johnson, John Kingston, et al

Published Date May 2010 Volume 2010:2 Pages 47—55

DOI http://dx.doi.org/10.2147/EB.S9188

Published 19 May 2010

Paul Koons1, Scott Johnson2, John Kingston2, Gregory L Goodrich3

1Blind Rehabilitation Outpatient Specialist, Polytrauma Transitional Rehabilitation Program, Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, VA, USA; 2Western Blind Rehabilitation Center, VA Palo Alto Health Care System, Palo Alto, CA, USA; 3Optometric Research Fellowship Program, Psychology Service, VA Palo Alto Health Care System, Palo Alto, CA, USA

Abstract: The purpose of this paper is to describe the response of a Department of Veterans Affairs medical center’s development of a rehabilitation program for patients with hemianopsia. Hemianopsia affects significant numbers of troops returning from Afghanistan and Iraq and their neurological vision loss presented unique challenges in developing an appropriate and effective rehabilitation program. A literature review indicated that existing therapies lacked supporting scientific evidence and that Traumatic Brain Injury (TBI)-related vision loss affects large numbers of civilians. The increasing number of patients with TBI-related vision loss necessitated the development of an innovative program which combined elements of therapies that the literature suggested were most promising. In this paper we briefly review the literature, describe the rehabilitation program developed, and present case studies of two patients who incurred vision loss as a result of a motor vehicle accident and a gunshot wound. The intent of the article is to begin the documentation of our ongoing, evidence based neurological vision loss rehabilitation program. We also encourage others who do not currently do so to assess the need for implementing vision rehabilitation programs for patients with TBI-related vision loss.

Keywords: neurological vision loss, comprehensive neurological vision rehabilitation (CNVR)

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

A randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprost

E Randy Craven, Ching-Chi Liu, Amy Batoosingh, et al

Clinical Ophthalmology 2010, 4:1433-1440

Published Date: 6 December 2010

Fungus-mediated biological synthesis of gold nanoparticles: potential in detection of liver cancer

Chauhan A, Zubair S, Tufail S, Sherwani A, Sajid M, Raman SC, Azam A, Owais M

International Journal of Nanomedicine 2011, 6:2305-2319

Published Date: 12 October 2011

Intramyocardial sustained delivery of placental growth factor using nanoparticles as a vehicle for delivery in the rat infarct model

Binsalamah ZM, Paul A, Khan AA, Prakash S, Shum-Tim D

International Journal of Nanomedicine 2011, 6:2667-2678

Published Date: 31 October 2011

Neovascularization in Purtscher's retinopathy

Chan A, Fredrick DR, Leng T

Clinical Ophthalmology 2011, 5:1585-1587

Published Date: 3 November 2011

Insight into 144 patients with ocular vascular events during VEGF antagonist injections

Mansour AM, Shahin M, Kofoed PK, Parodi MB, Shami M, Schwartz SG

Clinical Ophthalmology 2012, 6:343-363

Published Date: 6 March 2012

Update on neuromyelitis optica: natural history and management

Jindahra P, Plant GT

Eye and Brain 2012, 4:27-41

Published Date: 28 March 2012

Self-assembled mPEG–PCL-g–PEI micelles for simultaneous codelivery of chemotherapeutic drugs and DNA: synthesis and characterization in vitro

Shi S, Zhu XC, Guo QF, Wang YJ, Zuo T, Luo F, Qian ZY

International Journal of Nanomedicine 2012, 7:1749-1759

Published Date: 30 March 2012

Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivo

Cai L, Wang X, Wang W, Qiu N, Wen J, Duan X, Li X, Chen X, Yang L, Qian Z, Wei Y, Chen L

International Journal of Nanomedicine 2012, 7:4499-4510

Published Date: 14 August 2012

Bioconjugates of PAMAM dendrimers with trans-retinal, pyridoxal, and pyridoxal phosphate

Filipowicz A, WoĊ‚owiec S

International Journal of Nanomedicine 2012, 7:4819-4828

Published Date: 6 September 2012

RANTES and fibroblast growth factor 2 in jawbone cavitations: triggers for systemic disease?

Lechner J, von Baehr V

International Journal of General Medicine 2013, 6:277-290

Published Date: 22 April 2013